Massachusetts General Hospital

presented by
Daily

Medstro wants to redefine healthcare social media

Another startup has jumped into the healthcare social media space, hoping to capitalize on the evolving web habits of young physicians and med students. But unlike others that have emerged in the area, Boston-based Medstro is looking to not only seize the web for collaboration, but also hosting events and collaborative competitions that it hopes will spur […]

Daily

Ebola a ‘teachable moment’ for hospitals and EHRs

After the debacle in Dallas with Texas Health Resources and the false assertion that the EHR was to blame for not catching America’s first case of Ebola, the usability of EHRs has been a focal discussion point for hospital administrators and the health IT crowd. The problem, officials with Texas Health Resources said at the […]

Daily

Mass General, MIT form alliance to address three ‘major challenges’ in healthcare

Massachusetts General Hospital and MIT have formed a $3 million strategic alliance in an attempt to address three “major challenges” that persist in healthcare: improving diagnoses, developing new approaches to prevent and treat infectious diseases and developing more accurate methods of diagnosing and treating neurodegenerative and psychiatric diseases. The alliance, officials said, will add further […]

Devices & Diagnostics

California startup creates less invasive device that aims to answer advanced fetal monitoring questions

A California-based startup may finally help physicians monitor vital signs for fetuses of obese mothers, starting with heartrate. First Pulse Medical hopes to have the intrauterine device, which is noninvasive to the fetus, cleared with the FDA by the summer of 2014. Right now, physicians use an ultrasound stomach belt to monitor fetal heartrate, which […]

Devices & Diagnostics

One to watch: Medical device company says eye test can diagnose Alzheimer’s

Cognoptix, Inc. claims to have created a working, in-office, non-invasive eye-scan that detects Alzheimer’s earlier in patients. The SAPPHIRE II tracks a beta amyloid (“Ab”) signature in the eyes of potential Alzheimer’s patients. In a 10-subject, proof-of-concept clinical trial, the drug-device picked up a 200 percent differentiation factor between five healthy volunteers and five patients […]